Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Intangibles (2017 - 2025)

Historic Intangibles for Adma Biologics (ADMA) over the last 9 years, with Q3 2025 value amounting to $491000.0.

  • Adma Biologics' Intangibles fell 9117.86% to $491000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $491000.0, marking a year-over-year decrease of 9117.86%. This contributed to the annual value of $460000.0 for FY2024, which is 9118.27% down from last year.
  • Latest data reveals that Adma Biologics reported Intangibles of $491000.0 as of Q3 2025, which was down 9117.86% from $527000.0 recorded in Q2 2025.
  • Adma Biologics' 5-year Intangibles high stood at $6.1 million for Q1 2021, and its period low was $452000.0 during Q1 2025.
  • Moreover, its 5-year median value for Intangibles was $5.0 million (2021), whereas its average is $4.3 million.
  • Per our database at Business Quant, Adma Biologics' Intangibles soared by 1115.4% in 2024 and then plummeted by 9136.09% in 2025.
  • Over the past 5 years, Adma Biologics' Intangibles (Quarter) stood at $5.0 million in 2021, then fell by 0.01% to $5.0 million in 2022, then rose by 4.19% to $5.2 million in 2023, then tumbled by 91.18% to $460000.0 in 2024, then increased by 6.74% to $491000.0 in 2025.
  • Its last three reported values are $491000.0 in Q3 2025, $527000.0 for Q2 2025, and $452000.0 during Q1 2025.